Login to Your Account



Clinic Roundup


Wednesday, March 6, 2013
• Northwest Biotherapeutics Inc., of Bethesda, Md., said its Phase I/II DCVax-Direct trial for all inoperable solid tumor cancers is planned to start within the next 60 days.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription